In an interview with Pharmacy Times during the 2026 Cardiology Day of Education, Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-Cardiology), CACP, a cardiovascular clinical pharmacist with Baptist Health System and adjunct associate professor at the University of Kentucky College of Pharmacy, discussed the pharmacist's critical role in recognizing, evaluating, and managing transthyretin amyloidosis cardiomyopathy (ATTR-CM).
Beavers emphasized that patients with heart failure who fail to tolerate guideline-directed medical therapy represent a key clinical red flag for ATTR-CM, alongside other diagnostic signals such as carpal tunnel syndrome, aortic stenosis, and polyneuropathy. He stressed that pharmacists should avoid dismissing these patients as simply difficult to manage
